BIOGEN ($BIIB) posted quarterly earnings results on Thursday, July 31st. The company reported earnings of $5.47 per share, beating estimates of $3.94 by $1.53. The company also reported revenue of $2,645,500,000, beating estimates of $2,369,613,448 by $275,886,552.
You can see Quiver Quantitative's $BIIB stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BIOGEN Insider Trading Activity
BIOGEN insiders have traded $BIIB stock on the open market 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $BIIB stock by insiders over the last 6 months:
- STEPHEN A SHERWIN sold 8,760 shares for an estimated $1,314,141
- PRIYA SINGHAL (Head of Development) sold 3,806 shares for an estimated $480,507
- RACHID IZZAR (Head of Global Product Strat.) sold 2,223 shares for an estimated $300,105
- CAROLINE DORSA purchased 1,235 shares for an estimated $151,559
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BIOGEN Hedge Fund Activity
We have seen 424 institutional investors add shares of BIOGEN stock to their portfolio, and 395 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BEUTEL, GOODMAN & CO LTD. removed 1,746,467 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $238,986,544
- PACER ADVISORS, INC. removed 1,314,971 shares (-49.3%) from their portfolio in Q1 2025, for an estimated $179,940,631
- AQR CAPITAL MANAGEMENT LLC added 829,150 shares (+153.6%) to their portfolio in Q1 2025, for an estimated $113,460,886
- PRICE T ROWE ASSOCIATES INC /MD/ removed 782,524 shares (-40.5%) from their portfolio in Q1 2025, for an estimated $107,080,584
- BALYASNY ASSET MANAGEMENT L.P. added 740,390 shares (+1615.5%) to their portfolio in Q1 2025, for an estimated $101,314,967
- OVERSEA-CHINESE BANKING CORP LTD added 736,301 shares (+1663.4%) to their portfolio in Q1 2025, for an estimated $100,755,428
- SG AMERICAS SECURITIES, LLC added 719,793 shares (+inf%) to their portfolio in Q1 2025, for an estimated $98,496,474
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BIOGEN Government Contracts
We have seen $65,214 of award payments to $BIIB over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- QALSODY BULK: $43,476
- EMERGENCY PHARMACEUTICAL - QUALSODY (TOFERSEN): $21,738
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
BIOGEN Congressional Stock Trading
Members of Congress have traded $BIIB stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $BIIB stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 3 times. They made 2 purchases worth up to $30,000 on 05/15, 02/25 and 1 sale worth up to $15,000 on 04/08.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
BIOGEN Analyst Ratings
Wall Street analysts have issued reports on $BIIB in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 06/27/2025
- HC Wainwright & Co. issued a "Buy" rating on 06/26/2025
- Mizuho issued a "Outperform" rating on 05/07/2025
- Baird issued a "Outperform" rating on 05/02/2025
- Canaccord Genuity issued a "Buy" rating on 05/02/2025
- Truist Securities issued a "Buy" rating on 04/29/2025
- Goldman Sachs issued a "Buy" rating on 04/23/2025
To track analyst ratings and price targets for BIOGEN, check out Quiver Quantitative's $BIIB forecast page.
BIOGEN Price Targets
Multiple analysts have issued price targets for $BIIB recently. We have seen 16 analysts offer price targets for $BIIB in the last 6 months, with a median target of $172.0.
Here are some recent targets:
- Brian Abrahams from RBC Capital set a target price of $213.0 on 06/27/2025
- Andrew Fein from HC Wainwright & Co. set a target price of $187.0 on 06/26/2025
- David Amsellem from Piper Sandler set a target price of $115.0 on 06/12/2025
- Laura Chico from Wedbush set a target price of $121.0 on 06/12/2025
- Salim Syed from Mizuho set a target price of $169.0 on 05/07/2025
- Chris Schott from JP Morgan set a target price of $175.0 on 05/05/2025
- Sumant Kulkarni from Canaccord Genuity set a target price of $220.0 on 05/02/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
